Smith & Nephew Share Discussion Threads

[suetballs] 04/8/2022 10:41:57

Perhaps £10 was the bottom - hope so.
Looking a bit better today.
Suet

[hubshank] 03/8/2022 22:10:54

A Chartist would agree that the sell off has indeed been over done, as per post below. I suspect bounce will be quicker than some other stocks as we all need medical supplies, more so than once upon a time when a career as a barber was a safe bet. Covid, long hair and beards have put oau to that certainty

[csalvage] 02/8/2022 12:57:13

Going to start to drip feed into these can't call bottom but feel that it will bounce back again.

[suetballs] 02/8/2022 11:08:11

Price drop may well be over done but looks like sub £10 could be soon.
Very unloved here and I can't see a catalyst for an upturn.
Investing isn't much fun atm.
Suet

[berny3] 30/7/2022 18:24:35

in light of the price drop after earnings. The transcript of the earnings call is in the below link and also a recording of the call. personally I think the price drop is over done. In particular it is worth listening to the questions at the end. focus was made on this and i think good answers were given. www.seekingalpha.com/article/4527703-smith-and-nephew-plc-snn-ceo-deepak-nath-on-q2-2022-results-earnings-call-transcript

[montyhedge] 29/7/2022 21:00:15

I don't see any need to jump in, these could go lower, high p.e in my opinion.

[essentialinvestor] 29/7/2022 12:20:08

In case people missed the transaction from 23 May.

[essentialinvestor] 29/7/2022 12:19:33

Follow da leader ;


1. VESTING OF A CONDITIONAL AWARD GRANTED UNDER AN AWARD AGREEMENT DATED 29 APRIL 2022
On 23 May 2022, the Conditional Award of US$0.20 ordinary shares (the "Shares") in Smith & Nephew plc (the "Company") vested over 70,378 Shares. The resultant Shares post-vest were sold on 23 May 2022. Proceeds from the sale of sufficient Shares were utilised to satisfy the taxes due. As previously announced the Conditional Award formed part of buy-out awards in respect of outstanding incentives Deepak Nath forfeited upon leaving his former company.


Reason for the notification
Initial notification Initial notification
/Amendment
----------------------------------------------
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
Name Smith & Nephew plc
----------------------------------------------
LEI 213800ZTMDN8S67S1H61
----------------------------------------------
Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
Description of the Smith & Nephew plc ordinary shares of
financial instrument, USD 0.20 each
type of instrument
----------------------------------------------
Identification code ISIN: GB0009223206
----------------------------------------------
Nature of the transaction Vesting of a Conditional Award and subsequent
sale of all Shares .
----------------------------------------------
Date of Transaction 2022 - 05 - 23
----------------------------------------------
Place of Transaction London Stock Exchange (XLON)
---------------------------------

[lovewinshatelosses] 28/7/2022 15:59:18

Had this one on my radar for a while, waiting for a potentially suitable entry point. IMO it remains too pricey, all things considered. Really like the company in principle and the market they operate in long term seems extremely strong. Will keep watching from the sidelines. I might not get the chance, but not tempted at these levels anyway. GLA.

[essentialinvestor] 28/7/2022 15:12:06

I'm using their Melolin dressings atm following foot surgery, have to redress
every 2 day which is a right pain, luckily my better half works in healthcare.


If you are an optimist you might see today as kitchen sinking by the new CEO, perhaps.

[justiceforthemany] 28/7/2022 15:05:01

Shares are now HALF what they were pre pandemic. Sales will only increase moving forward and the Orthopaedic back log is huge. China adversely affected H1.

[justiceforthemany] 28/7/2022 15:03:47

EI that CEO sale was apparently forced - see IR response

The sales that were reported immediately followed receipt of a share award, that was made as part of buying out outstanding share awards from Deepak Nath's former company, that he had to forfeit upon leaving that company to join Smith+Nephew. It does not relate to any business developments.

Looking forward, the Chief Executive Officer is required to hold three times his salary in the form of shares, with a time of five years from his appointment to meet that requirement.

[roguetraderuk] 28/7/2022 13:51:43

jnj is prob no1 but only once they split which wont be happening for sometime. and re the price, yes here its not a bargain given the premium that needs to be paid. i dont think anyone is going to look at this in terms of m&a while abv 10 pounds. there are plenty of variables but i think buyers will want to be paying not a great deal abv current levels which means it would need to fall further to reflect a premium then.

[essentialinvestor] 28/7/2022 13:47:30

Surprised that no one commented on the large CEO share dump a few week back -

Those shares granted in lieu of the lapsed options in his previous role on
taking the SN position.

[essentialinvestor] 28/7/2022 13:44:49

£13/4 bn to take this out - plus their £2 bn approx in net debt.


Is SN. worth £15 bn...looks a stretch to me but never say never.


Stryker already carry a lump of debt, realistically only leaves JnJ imv.

[justiceforthemany] 28/7/2022 13:36:49

Will be taken over. Question of when not if.

[essentialinvestor] 28/7/2022 12:39:40

You read his posts?, seriously, really?.

[wad collector] 28/7/2022 12:27:42

Now be honest , would it be true to say that almost all your postings have been negative about every share from long before Covid appeared?

[porsche1945] 28/7/2022 11:09:30

Another dog ftse 100 index company, the whole index is uninvestable, all these dire U.K. businesses now being found out. Shoes just keep dropping.

[roguetraderuk] 28/7/2022 10:16:41

ian, the bigger discrepancy between it and competitors and esp if pound stays weak the bigger the chance of m&a. but remember the shark needs to offer a premium to the 12 month price. i think anyone bidding for it wont want to pay more than 14/15 pounds so they may be happy to wait this one out. if the shares were to fall under 950 it could see a move to 600 thats just purely technical.

[roguetraderuk] 28/7/2022 10:13:40

if you convert to pounds (analysts were expecting about $750m ni so about 615m pounds) and knock 50m off net income it gets you 575 for full year and with a mktcap of just over 9bn you are on about 16 and a half for this year.

[ianood] 28/7/2022 10:04:29

Should have read ortho as in orthopaedics!!!

[ianood] 28/7/2022 10:03:10

I think this companies mgt is pretty useless and still trying to sort the ongoing orthodox issues. Must be ripe for the likes of Spyker to consider?

[essentialinvestor] 28/7/2022 09:47:20

Can't see previous FY earnings estimates being achieved as SN
now appear to be guiding lower on margin for the full year ?.

[roguetraderuk] 28/7/2022 09:44:14

it was seen as pretty defensive so maybe thats why it never got to single fig pe. presently they are 17/16/15 times current and next which doesnt quite put them in the value hunter camp so theres no need to go overboard here. ive been trying to leg in and out, maintaining a position but keeping the avg going down, i presently own an eighth possie from 1125 so not keen on adding at present. nick train mentioned these a bit higher up but made it clear he wasnt interested at those prices. i think below 10 pounds a few people will start to look at them.